Continuous Renal Replacement Therapy (CRRT) Market Size, Share & Industry Analysis, By Product (Systems, and Consumables), By Modality (Slow Continuous Ultra-Filtration {SCUF}, Continuous Venovenous Hemofiltration {CVVH}, Continuous Venovenous Hemodialysis {CVVHD}, and Continuous Venovenous Hemodiafiltration {CVVHDF}), and Regional Forecast, 2019-2026 (Includes COVID-19 Business Impact)

                                          
We have updated Continuous Renal Replacement Therapy (CRRT) Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Continuous Renal Replacement Therapy (CRRT) market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Continuous Renal Replacement Therapy (CRRT) market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Continuous Renal Replacement Therapy (CRRT) Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Continuous Renal Replacement Therapy (CRRT) Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Continuous Renal Replacement Therapy (CRRT) Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

Innovation, and Geographical Expansion of Baxter International Inc., has Propelled the Company to a Leading Position in the Global Market

Thecompetition landscape of the continuous renal replacement therapy market represents a monopoly market, dominated by Baxter International Inc. A diversified product portfolio of unique continuous renal replacement therapy (CRRT) technology in critical care, along with constant innovations by the company leading to new device introductions, are some of the prominent factors responsible for the dominance of the company.
However, the regional and domestic players such as B. Braun Melsungen AG, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, NxStage Medical, Inc., Toray Medical Co., NIPRO Corporation, Ltd, Medtronic plc, and others have entered the continuous renal replacement therapy market with innovative technology devices. Thus, they are anticipated to impact the global market positively, and these companies are likely to gain more market share during the forecast period.

LIST OF KEY COMPANIES PROFILED:

  
Baxter International Inc.
  
B. Braun Medical Inc.
  
Fresenius Medical Care AG & Co. KGaA
  
Asahi Kasei Corporation
  
NIPRO Corporation
  
Toray Medical Co., Ltd
  
NxStage Medical, Inc.,
  
Medtronic plc
  
Other key market players

KEY INDUSTRY DEVELOPMENTS:

February 2019 Fresenius Medical Care announced its acquisition of NxStage Medical following the approval by antitrust authorities in the United States. With the help of this acquisition, Fresenius Medical Care is enabled to leverage its supply chain, manufacturing, and marketing competencies across the dialysis products, services, and care coordination businesses in a less labor- and capital-intensive care setting.

October 2018  Baxter International Inc. received the CE mark of both its products, i.e., PrisMax system and TherMax blood warmer. PrisMax is the company"s next-generation technology for continuous renal replacement and organ support therapies. Designed with the effort from more than 650 healthcare practitioners worldwide, the PrisMax system features innovative technology to provide accurate, simpler, efficient, and improved therapy treatment in the ICU. TherMax blood warmer, is used alongside the PrisMax system, and is a critical component for extracorporeal therapies as a patients blood is purified outside of the body and must be at a certain temperature prior to returning to the body.

REPORT COVERAGE

The Continuous renal replacement therapy market report provides a detailed analysis of the market and focuses on key aspects such as leading companies, product types, and leading modalities types. Besides, the report offers insights into the Continuous Renal Replacement Therapy market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the market over recent years.

Report Scope & Segmentation

 Segmentation

By Product Type

  
System
  
Consumables

By Modality

  
Slow Continuous Ultra Filtration (SCUF)
  
Continuous Venovenous Hemofiltration (CVVH)
  
Continuous Venovenous Hemodialysis (CVVHD)
  
Continuous Venovenous Hemodiafiltration (CVVHDF)

By Geography

  
North America (U.S. and Canada)
  
Europe (U.K., Germany, and Rest of Europe)
  
Asia Pacific (Japan, China, and Rest of Asia Pacific)
  
Latin America (Brazil, Mexico, and Rest of Latin America)
  
Middle East & Africa (South Africa, Rest of the Middle East & Africa)